AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymat Tablet

Prescription Icon
Prescription Required

Marketer

Ind Swift Laboratories Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glymat Tablet

Diabex Duo, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combination therapy regulates blood glucose. Administer Diabex Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Diabex Duo complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a rapid-acting glucose source (e.g., sugary snacks, juice) to counter hypoglycemia. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before using Diabex Duo if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are necessary.

Primary Ingredients of Glymat Tablet

No text provided to rephrase.

Uses of Glymat Tablet

Adult-onset diabetes

Major Benefits of Glymat Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glymat Tablet with a meal.

Common Side effects of Glymat Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glymat Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glymat Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Glymat Tablet with food.

How Glymat Tablet works:

Glymat tablets contain a dual-action formulation, combining the antidiabetic agents gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Glymat Tablets should not be taken together.

PregnancyPregnancyCONSULT YOUR DOCTOR

Taking Glymat Tablet during pregnancy is considered unsafe due to confirmed risks to the unborn child. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glymat Tablet while breastfeeding is likely inadvisable. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glymat Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glymat Tablet use. Consult your physician. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glymat Tablet cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; Glymat Tablet is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glymat Tablet :

Should you forget a Glymat Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymat Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glymat Tablet

Glymat Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glymat Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, can also occur. Prolonged use may result in vitamin B12 deficiency.
Glymat Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glymat Tablet use can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glymat Tablet and seek immediate medical attention.
Prolonged Glymat Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glymat Tablet is contraindicated in patients with hypersensitivity to any ingredient or excipient. Its use should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol while taking Glymat tablets is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Glymat Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glymat Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glymat Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glymat Tablet use can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is preventable by avoiding Glymat in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glymat and seek immediate medical attention.
Prolonged Glymat Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Glymat Tablet is contraindicated in patients allergic to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glymat tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glymat Tablet
50
MRP 62
18% off